ArticleCancer medicine2022
"It's something I'll do until I die": A qualitative examination into why older women in the U.S. continue screening mammography.
Article in Cancer medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- The effect of conflicting versus consistent messaging on older women's support for breast cancer screening cessation.Patient education and counseling · 2025Trial
- Use of a Discrete Choice Experiment to Inform De-implementation of Mammography Overscreening: A US-Based National Survey.Journal of general internal medicine · 2026Article
- Application of Innovation Tournament methodology to inform de-implementation strategies: lessons learned in addressing mammography overscreening in older women.Implementation science communications · 2026Article
- What Information on Mammographic Screening is Available to Women in Quebec, Ontario and Canada: Results from a Document Analysis.Public health ethics · 2026Article
- Social Drivers of Guideline-Discordant Breast Cancer Screening by Age and Mortality Risk.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026Article
- Understanding motivations of older women to continue or discontinue breast cancer screening.medRxiv : the preprint server for health sciences · 2025Article
- Understanding motivations of older women to continue or discontinue breast cancer screening.PloS one · 2025Article
- Breast cancer screening motivation and behaviours of women aged over 75 years: a scoping review.BMC women's health · 2024Article
- Perceived Barriers Among Clinicians and Older Adults Aged 65 and Older Regarding Use of Life Expectancy to Inform Cancer Screening: A Narrative Review and Comparison.Medical care research and review : MCRR · 2023Review
- To Consent or Not to Consent to Screening, That Is the Question.Healthcare (Basel, Switzerland) · 2023Article
- "It's something I'll do until I die": A qualitative examination into why older women in the U.S. continue screening mammography.Cancer medicine · 2022Article
- Older women's lived experience of ageism: Breast cancer screening beyond the targeted age range.Women's health (London, England)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundProfessional guidelines in the U.S. do not recommend routine screening mammography for women ≥75 years with limited life expectancy and/or poor health. Yet, routine mammography remains widely used in older women. We examined older women's experiences, beliefs, and opinions about screening mammography in relation to aging and health.
methodsWe performed thematic analysis of transcribed semi-structured interviews with 19 women who had a recent screening visit at a mammography clinic in New York City (average age: 75 years, 63% Hispanic, 53% ≤high school education).
resultsThree main themes emerged: (1) older women typically perceive mammograms as a positive, beneficial, and routine component of care; (2) participation in routine mammography is reinforced by factors at interpersonal, provider, and healthcare system levels; and (3) older women do not endorse discontinuation of screening mammography due to advancing age or poor health, but some may be receptive to reducing screening frequency. Only a few older women reported having discussed mammography cessation or the potential harms of screening with their providers. A few women reported they would insist on receiving mammography even without a provider recommendation.
conclusionsOlder women's positive experiences and views, as well as multilevel and frequently automated cues toward mammography are important drivers of routine screening in older women. These findings suggest a need for synergistic patient, provider, and system level strategies to reduce mammography overuse in older women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.